Loss of GAS5 Tumour Suppressor lncRNA: An Independent Molecular Cancer Biomarker for Short-Term Relapse and Progression in Bladder Cancer Patients

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0320-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Loss of SPARC in Bladder Cancer Enhances Carcinogenesis and Progression

Journal of Clinical Investigation
Medicine
2013English

Serum Matrix Metalloproteinase-7 Is an Independent Prognostic Biomarker in Advanced Bladder Cancer

Clinical and Translational Medicine
MedicineMolecular Medicine
2014English

Role of Progranulin Gene Expression as a Molecular Biomarker for Bladder Cancer

American Journal of Biochemistry and Biotechnology
BiochemistryBiotechnology
2012English

LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2018English

The Proportion of Tumour Cells Is an Independent Predictor for Survival in Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2010English

Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression

American Journal of Pathology
Forensic MedicinePathology
2010English

Loss of P63 Expression Is Associated With Tumor Progression in Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2002English

A Novel Biomarker for Diagnosis of Bladder Cancer

Folia Pharmacologica Japonica
Pharmacology
2015English

Bladder Cancer-Associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy